Elevated interleukin-6 is associated with severity of COVID-19: A meta-analysis.

Zhu, Jieyun; Pang, Jielong; Ji, Pan; Zhong, Zhimei; Li, Hongyuan; Li, Bocheng; Zhang, Jianfeng

Zhu, Jieyun; Pang, Jielong; Ji, Pan; Zhong, Zhimei; Li, Hongyuan; Li, Bocheng; Zhang, Jianfeng.

Zhu J; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Pang J; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ji P; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhong Z; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li H; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li B; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhang J; Department of Emergency Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.

J Med Virol ; 93(1): 35-37, 2021 01.

Article in English | MEDLINE | ID: covidwho-437061

Subject(s)

COVID-19/immunology; Interleukin-6/blood; Biomarkers; COVID-19/mortality; Critical Illness; Humans; Inflammation/virology; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Type of study: Prognostic study / Reviews Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26085

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google